Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB1 receptors
- 5 July 2001
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 423 (2-3) , 203-210
- https://doi.org/10.1016/s0014-2999(01)01112-8
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Vanilloid receptors on capsaicin‐sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteriesBritish Journal of Pharmacology, 2000
- Cardiovascular effects of endocannabinoids—the plot thickensProstaglandins & Other Lipid Mediators, 2000
- Mesenteric Vasodilation Mediated by Endothelial Anandamide ReceptorsHypertension, 1999
- Cannabinoid CB1 receptor and endothelium‐dependent hyperpolarization in guinea‐pig carotid, rat mesenteric and porcine coronary arteriesBritish Journal of Pharmacology, 1998
- Mechanism of the Hypotensive Action of Anandamide in Anesthetized RatsHypertension, 1996
- Cardiovascular Effects of (-)-11-OH-Δ8-Tetrahydrocannabinol-Dimethylheptyl in RatsJournal of Cardiovascular Pharmacology, 1996
- Cardiovascular effects of centrally administered endothelin-1 and its relationship to changes in cerebral blood flowLife Sciences, 1995
- Regional Cerebral Blood Flow after Marijuana SmokingJournal of Cerebral Blood Flow & Metabolism, 1992
- Suitability of urethane anesthesia for physiopharmacological investigations in various systems Part 1: General considerationsCellular and Molecular Life Sciences, 1986